Pages that link to "Q33604453"
Jump to navigation
Jump to search
The following pages link to Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database (Q33604453):
Displaying 16 items.
- A mathematical model of multisite phosphorylation of tau protein (Q48097704) (← links)
- The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review. (Q52585260) (← links)
- Decreased Bilateral FDG-PET Uptake and Inter-Hemispheric Connectivity in Multi-Domain Amnestic Mild Cognitive Impairment Patients: A Preliminary Study. (Q55255360) (← links)
- Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease (Q58698516) (← links)
- Alzheimer's disease: 3-Dimensional MRI texture for prediction of conversion from mild cognitive impairment (Q59336905) (← links)
- Amyloid beta in nasal secretions may be a potential biomarker of Alzheimer's disease (Q64067946) (← links)
- Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging (Q64099240) (← links)
- Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment. (Q64934882) (← links)
- Can composite digital monitoring biomarkers come of age? A framework for utilization (Q88508417) (← links)
- Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer's Disease Continuum (Q90263503) (← links)
- The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease (Q90450363) (← links)
- Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes (Q90727860) (← links)
- Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease (Q92283796) (← links)
- Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort (Q92538620) (← links)
- Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative (Q93228743) (← links)
- Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort (Q97885120) (← links)